As Per Coherent Market Insights report, by 2027,Drug-Device Combination Products Market To Reach US$ 214.1 Billion


Posted July 16, 2020 by adwaitcoherent

Drug-Device Combination Products Market To Reach from US$ 115.0 Bn in 2019 to US$ 214.1 Bn in 2027 with CAGR growth of 8.1%
 
Request for Sample PDF Copy: https://www.coherentmarketinsights.com/insight/request-sample/3919
Description:
Global Drug-Device Combination Products Market: Drivers
Approval and availability of drug-device combination products is expected to propel growth of the global drug-device combination products market over the forecast period. For instance, in July 2019, Walgreens, a pharmacy store chain, and Kaléo, a privately-held pharmaceutical company, announced AUVI-q (epinephrine injection, USP) 0.1 mg auto-injector – the first and only epinephrine auto-injector approved by the U.S. FDA for infants and toddlers is available at Walgreens locations.
Global Drug-Device Combination Products Market: Opportunities
R&D in combination products is expected to offer lucrative growth opportunities for players in the global drug-device combination products market. For instance, in November 2019, Boston Scientific Corporation announced positive data for Eluvia Drug-Eluting Vascular Stent for the treatment of femoropopliteal disease.
Global Drug-Device Combination Products Market: Restraints
Product recalls are expected to hinder growth of the market. For instance, in October 2019, Medtronic plc recalled Medtronic SynchroMed II implantable drug infusion pump due to potential presence of foreign particles inside the pump motor assembly.
Key Takeaways:
The global drug-device combination products market was valued at US$ 115.0 Bn in 2019 and is forecast to reach a value of US$ 214.1 Bn by 2027 at a CAGR of 8.1% between 2020 and 2027. Major factor driving the growth of global drug-device combination products market during the forecast period increasing prevalence of chronic diseases, and product launches.
North America held dominant position in the global drug-device combination products market in 2019, accounting for 41.4% share in terms of value, followed by Europe and Asia Pacific, respectively. Presence of leading manufacturers and product launches is expected to support growth of the market over the forecast period.
Market Trends
Major players in the market are focused on adopting M&A strategies to expand their product portfolio. For instance, in February 2020, Integer Holdings Corporation acquired Inomec, an Israel-based manufacturer of medical devices, including minimally invasive tools, delivery systems, metal implants, drug-device combination devices, and laser processing services
Major players in the market are also focused on conducting clinical trials for approval and launch of new products. For instance, in July 2019, SINOMED completed enrollment in the PIONEER III randomized, controlled clinical trial to assess the safety and effectiveness of the BuMA Supreme DES in order to obtain key regulatory approvals for the BuMA Supreme Drug-Eluting Stent (DES) System.
Global Drug-Device Combination Products Market: Competitive Landscape
Major players operating in the global drug-device combination products market include, Teva Pharmaceutical Industries Ltd., Becton, Dickinson and Company, Integer Holdings Corporation, Abbott Laboratories, Medtronic plc, Allergan, Inc., Alcon, Inc., Arrow International, Inc., Bausch & Lomb, Inc., Boston Scientific Corporation, ALK, SINOMED, Kaléo, Haselmeier, Flowonix Medical, Inc., CareFusion Corporation, and Covidien PLC.
Global Drug-Device Combination Products Market: Key Developments
December 2019: Kaléo collaborated with HealthFirst and MedAire, emergency medical kit distributors, to offer Auvi-Q 0.3 mg and Auvi-Q 0.15 mg auto-injectors in the American Airlines’ emergency medical kits
August 2019: ALK launched new epinephrine auto-injector that is designed to be small, easy-to-use, heat-stable, and with a long shelf life, in the U.S.
Buy this Research Report: https://www.coherentmarketinsights.com/insight/buy-now/3919
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We do offer wide range of services such as Industry analysis, Consulting services, Market Intelligence, Customized research services and much more. We have expertise in many fields such as healthcare, chemicals and materials, Automation, semiconductors, electronics, energy, food and beverage, packaging and many more. Visit our website to know more.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave.
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By https://www.coherentmarketinsights.com/
Business Address Coherent Market Insights 1001 4th Ave,
#3200 Seattle, WA 98154, U.S.
Country United States
Categories Health , Marketing , Research
Tags coronary stent , drug eluting stents , drugdevice combination products market analysis , peripheral vascular stents , photosensitizers
Last Updated July 16, 2020